BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 10119188)

  • 1. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.
    Pastel DA; Chang S; Nessim S; Shane R; Morgan MA
    Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streamlining antimicrobial therapy through pharmacists' review of order sheets.
    Briceland LL; Lesar TS; Lomaestro BM; Lombardi TP; Gailey RA; Kowalsky SF
    Am J Hosp Pharm; 1989 Jul; 46(7):1376-80. PubMed ID: 2757043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Culture and antibiotic monitoring service in a community hospital.
    Von Seggern RL
    Am J Hosp Pharm; 1987 Jun; 44(6):1358-62. PubMed ID: 3303924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
    Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA
    Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital.
    Rüttimann S; Keck B; Hartmeier C; Maetzel A; Bucher HC
    Clin Infect Dis; 2004 Feb; 38(3):348-56. PubMed ID: 14727204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D; Thornton J
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a pharmacist/physician cooperative target drug monitoring program on prophylactic antibiotic prescribing in obstetrics and gynecology.
    Michael KA; Henderson PL; Newman RB; Blackwelder EN; Caldwell RD
    Hosp Pharm; 1992 Mar; 27(3):213-6. PubMed ID: 10116721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of clinical pharmacists to cefazolin utilization.
    Witte KW; Hatoum HT; Hoon TJ
    Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach.
    Briceland LL; Nightingale CH; Quintiliani R; Cooper BW; Smith KS
    Arch Intern Med; 1988 Sep; 148(9):2019-22. PubMed ID: 3415406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of pharmacist interventions.
    Torchinsky A; Landry D
    Can J Hosp Pharm; 1991 Oct; 44(5):245-8, 270. PubMed ID: 10115578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial.
    Schouten JA; Hulscher ME; Trap-Liefers J; Akkermans RP; Kullberg BJ; Grol RP; van der Meer JW
    Clin Infect Dis; 2007 Apr; 44(7):931-41. PubMed ID: 17342644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a hospital-based target drug program on institutional and community prescribing behavior.
    Taketomo RT; Andersen RC; Sherwood CL; Findley CI
    Am J Hosp Pharm; 1989 Sep; 46(9):1784-6. PubMed ID: 2801711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the impact of education by a clinical pharmacist on antibiotic prescribing and administration in an acute care state psychiatric hospital.
    Thompson BF; Miller WA; Wells BG; Rawls WN
    Hosp Pharm; 1986 Nov; 21(11):1056-62. PubMed ID: 10279323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic impact of clinical pharmacists' unsolicited recommendations.
    Torok N; Brown G
    Hosp Pharm; 1992 Dec; 27(12):1052-3, 1056-8, 1060. PubMed ID: 10122507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic cost control measures in a hospital pharmacy.
    Manzo J; Amodio-Groton MA; Kleinmann K
    Clin Ther; 1993; 15 Suppl A():37-43. PubMed ID: 8513460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical results and costs due to improved antibiotics policies].
    Gyssens IC; Kullberg BJ; van der Meer JW
    Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2361-4. PubMed ID: 10590774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance.
    Glowacki RC; Schwartz DN; Itokazu GS; Wisniewski MF; Kieszkowski P; Weinstein RA
    Clin Infect Dis; 2003 Jul; 37(1):59-64. PubMed ID: 12830409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pharmacists' clinical interventions on nonformulary drug use.
    Packer LA; Mahoney CD; Rich DS; Jeffrey LP
    Am J Hosp Pharm; 1986 Jun; 43(6):1461-6. PubMed ID: 3728481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pharmacist participation on a medical team on costs, charges, and length of stay.
    Haig GM; Kiser LA
    Am J Hosp Pharm; 1991 Jul; 48(7):1457-62. PubMed ID: 1882873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical approach enabling staff pharmacists to prospectively review and dose aminoglycoside therapy.
    Possidente CJ; Lynch T
    Hosp Pharm; 1988 Nov; 23(11):976-8, 981-3. PubMed ID: 10290757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.